Centessa Pharmaceuticals Statistics
Total Valuation
CNTA has a market cap or net worth of $3.24 billion. The enterprise value is $3.11 billion.
Important Dates
The next estimated earnings date is Tuesday, November 11, 2025, before market open.
| Earnings Date | Nov 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CNTA has 134.07 million shares outstanding. The number of shares has increased by 27.54% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 134.07M |
| Shares Change (YoY) | +27.54% |
| Shares Change (QoQ) | +0.48% |
| Owned by Insiders (%) | 0.75% |
| Owned by Institutions (%) | 57.84% |
| Float | 85.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 207.38 |
| Forward PS | n/a |
| PB Ratio | 9.38 |
| P/TBV Ratio | 9.39 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 207.02 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.12, with a Debt / Equity ratio of 0.34.
| Current Ratio | 10.12 |
| Quick Ratio | 9.93 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -19.12 |
Financial Efficiency
Return on equity (ROE) is -72.92% and return on invested capital (ROIC) is -30.88%.
| Return on Equity (ROE) | -72.92% |
| Return on Assets (ROA) | -28.96% |
| Return on Invested Capital (ROIC) | -30.88% |
| Return on Capital Employed (ROCE) | -44.64% |
| Revenue Per Employee | $194,805 |
| Profits Per Employee | -$2.99M |
| Employee Count | 77 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CNTA has paid $3.83 million in taxes.
| Income Tax | 3.83M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +59.41% in the last 52 weeks. The beta is 1.57, so CNTA's price volatility has been higher than the market average.
| Beta (5Y) | 1.57 |
| 52-Week Price Change | +59.41% |
| 50-Day Moving Average | 20.98 |
| 200-Day Moving Average | 16.25 |
| Relative Strength Index (RSI) | 64.95 |
| Average Volume (20 Days) | 1,008,516 |
Short Selling Information
| Short Interest | 4.99M |
| Short Previous Month | 5.51M |
| Short % of Shares Out | 4.57% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 5.01 |
Income Statement
In the last 12 months, CNTA had revenue of $15.00 million and -$230.37 million in losses. Loss per share was -$1.79.
| Revenue | 15.00M |
| Gross Profit | 15.00M |
| Operating Income | -206.42M |
| Pretax Income | -226.54M |
| Net Income | -230.37M |
| EBITDA | -206.11M |
| EBIT | -206.42M |
| Loss Per Share | -$1.79 |
Full Income StatementBalance Sheet
The company has $250.72 million in cash and $118.14 million in debt, giving a net cash position of $132.58 million or $0.99 per share.
| Cash & Cash Equivalents | 250.72M |
| Total Debt | 118.14M |
| Net Cash | 132.58M |
| Net Cash Per Share | $0.99 |
| Equity (Book Value) | 344.92M |
| Book Value Per Share | 2.58 |
| Working Capital | 270.67M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$143.89 million and capital expenditures -$160,000, giving a free cash flow of -$144.05 million.
| Operating Cash Flow | -143.89M |
| Capital Expenditures | -160,000 |
| Free Cash Flow | -144.05M |
| FCF Per Share | -$1.07 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -1,376.10% |
| Pretax Margin | -1,510.27% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CNTA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -27.54% |
| Shareholder Yield | -27.54% |
| Earnings Yield | -7.11% |
| FCF Yield | -4.45% |
Analyst Forecast
The average price target for CNTA is $31.29, which is 29.57% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $31.29 |
| Price Target Difference | 29.57% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CNTA has an Altman Z-Score of 3.85 and a Piotroski F-Score of 2.
| Altman Z-Score | 3.85 |
| Piotroski F-Score | 2 |
